vs
CF Industries（CF）与奎斯特诊断（DGX）财务数据对比。点击上方公司名可切换其他公司
奎斯特诊断的季度营收约是CF Industries的1.5倍（$2.9B vs $1.9B），CF Industries净利率更高（26.4% vs 9.7%，领先16.7%），CF Industries同比增速更快（22.8% vs 9.2%），过去两年CF Industries的营收复合增速更高（12.8% vs 9.9%）
CF Industries Holdings Inc.是美国知名农用肥料生产及分销商，1946年成立时名为中央农民肥料公司，总部位于芝加哥郊区的伊利诺伊州诺斯布鲁克。公司主营氨、尿素、硝酸铵等肥料产品，最初为区域农业供应合作社联盟，成立56年后完成股份化改制，转为公开上市企业。
奎斯特诊断是美国头部临床检验服务商，位列《财富》500强，业务覆盖美国、波多黎各、墨西哥及巴西，同时与全球范围内多家医院、诊所保持长期协作关系，为不同地区的客户提供专业临床检验相关服务。
CF vs DGX — 直观对比
营收规模更大
DGX
是对方的1.5倍
$1.9B
营收增速更快
CF
高出13.7%
9.2%
净利率更高
CF
高出16.7%
9.7%
两年增速更快
CF
近两年复合增速
9.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.9B | $2.9B |
| 净利润 | $495.0M | $281.0M |
| 毛利率 | 40.9% | — |
| 营业利润率 | 33.0% | 15.4% |
| 净利率 | 26.4% | 9.7% |
| 营收同比 | 22.8% | 9.2% |
| 净利润同比 | 26.3% | 12.0% |
| 每股收益（稀释后） | $2.56 | $2.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CFDGX
| Q1 26 | — | $2.9B | ||
| Q4 25 | $1.9B | $2.8B | ||
| Q3 25 | $1.7B | $2.8B | ||
| Q2 25 | $1.9B | $2.8B | ||
| Q1 25 | $1.7B | $2.7B | ||
| Q4 24 | $1.5B | $2.6B | ||
| Q3 24 | $1.4B | $2.5B | ||
| Q2 24 | $1.6B | $2.4B |
净利润CFDGX
| Q1 26 | — | $281.0M | ||
| Q4 25 | $495.0M | $245.0M | ||
| Q3 25 | $460.0M | $245.0M | ||
| Q2 25 | $492.0M | $282.0M | ||
| Q1 25 | $351.0M | $220.0M | ||
| Q4 24 | $392.0M | $222.0M | ||
| Q3 24 | $341.0M | $226.0M | ||
| Q2 24 | $506.0M | $229.0M |
毛利率CFDGX
| Q1 26 | — | — | ||
| Q4 25 | 40.9% | 32.4% | ||
| Q3 25 | 38.1% | 33.7% | ||
| Q2 25 | 39.9% | 34.2% | ||
| Q1 25 | 34.4% | 32.5% | ||
| Q4 24 | 34.4% | 32.7% | ||
| Q3 24 | 32.4% | 32.6% | ||
| Q2 24 | 43.2% | 33.5% |
营业利润率CFDGX
| Q1 26 | — | 15.4% | ||
| Q4 25 | 33.0% | 13.8% | ||
| Q3 25 | 35.0% | 13.7% | ||
| Q2 25 | 34.3% | 15.9% | ||
| Q1 25 | 27.4% | 13.0% | ||
| Q4 24 | 28.9% | 13.8% | ||
| Q3 24 | 26.6% | 13.3% | ||
| Q2 24 | 40.6% | 14.8% |
净利率CFDGX
| Q1 26 | — | 9.7% | ||
| Q4 25 | 26.4% | 8.7% | ||
| Q3 25 | 27.7% | 8.7% | ||
| Q2 25 | 26.0% | 10.2% | ||
| Q1 25 | 21.1% | 8.3% | ||
| Q4 24 | 25.7% | 8.5% | ||
| Q3 24 | 24.9% | 9.1% | ||
| Q2 24 | 32.2% | 9.6% |
每股收益（稀释后）CFDGX
| Q1 26 | — | $2.24 | ||
| Q4 25 | $2.56 | $2.18 | ||
| Q3 25 | $2.19 | $2.16 | ||
| Q2 25 | $2.37 | $2.47 | ||
| Q1 25 | $1.85 | $1.94 | ||
| Q4 24 | $1.86 | $1.95 | ||
| Q3 24 | $1.55 | $1.99 | ||
| Q2 24 | $2.30 | $2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $393.0M |
| 总债务越低越好 | $3.2B | $5.7B |
| 股东权益账面价值 | $4.8B | $7.7B |
| 总资产 | $14.1B | $16.7B |
| 负债/权益比越低杠杆越低 | 0.66× | 0.74× |
8季度趋势，按日历期对齐
现金及短期投资CFDGX
| Q1 26 | — | $393.0M | ||
| Q4 25 | — | $420.0M | ||
| Q3 25 | — | $432.0M | ||
| Q2 25 | — | $319.0M | ||
| Q1 25 | — | $188.0M | ||
| Q4 24 | — | $549.0M | ||
| Q3 24 | — | $764.0M | ||
| Q2 24 | — | $271.0M |
总债务CFDGX
| Q1 26 | — | $5.7B | ||
| Q4 25 | $3.2B | $5.2B | ||
| Q3 25 | $3.0B | $5.2B | ||
| Q2 25 | $3.0B | $5.2B | ||
| Q1 25 | $3.0B | $5.9B | ||
| Q4 24 | $3.0B | $5.6B | ||
| Q3 24 | $3.0B | $5.6B | ||
| Q2 24 | $3.0B | $3.8B |
股东权益CFDGX
| Q1 26 | — | $7.7B | ||
| Q4 25 | $4.8B | $7.2B | ||
| Q3 25 | $4.8B | $7.3B | ||
| Q2 25 | $5.0B | $7.2B | ||
| Q1 25 | $4.8B | $6.9B | ||
| Q4 24 | $5.0B | $6.8B | ||
| Q3 24 | $5.2B | $6.8B | ||
| Q2 24 | $5.5B | $6.6B |
总资产CFDGX
| Q1 26 | — | $16.7B | ||
| Q4 25 | $14.1B | $16.2B | ||
| Q3 25 | $14.2B | $16.2B | ||
| Q2 25 | $13.8B | $16.0B | ||
| Q1 25 | $13.3B | $15.8B | ||
| Q4 24 | $13.5B | $16.2B | ||
| Q3 24 | $13.8B | $16.1B | ||
| Q2 24 | $13.8B | $13.9B |
负债/权益比CFDGX
| Q1 26 | — | 0.74× | ||
| Q4 25 | 0.66× | 0.72× | ||
| Q3 25 | 0.61× | 0.71× | ||
| Q2 25 | 0.60× | 0.72× | ||
| Q1 25 | 0.62× | 0.85× | ||
| Q4 24 | 0.60× | 0.83× | ||
| Q3 24 | 0.57× | 0.83× | ||
| Q2 24 | 0.54× | 0.58× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $539.0M | $278.0M |
| 自由现金流经营现金流 - 资本支出 | $313.0M | — |
| 自由现金流率自由现金流/营收 | 16.7% | — |
| 资本支出强度资本支出/营收 | 12.1% | 3.9% |
| 现金转化率经营现金流/净利润 | 1.09× | 0.99× |
| 过去12个月自由现金流最近4个季度 | $1.8B | — |
8季度趋势，按日历期对齐
经营现金流CFDGX
| Q1 26 | — | $278.0M | ||
| Q4 25 | $539.0M | $465.0M | ||
| Q3 25 | $1.1B | $563.0M | ||
| Q2 25 | $563.0M | $544.0M | ||
| Q1 25 | $586.0M | $314.0M | ||
| Q4 24 | $420.0M | $464.0M | ||
| Q3 24 | $931.0M | $356.0M | ||
| Q2 24 | $475.0M | $360.0M |
自由现金流CFDGX
| Q1 26 | — | — | ||
| Q4 25 | $313.0M | $307.0M | ||
| Q3 25 | $717.0M | $419.0M | ||
| Q2 25 | $318.0M | $436.0M | ||
| Q1 25 | $454.0M | $197.0M | ||
| Q4 24 | $223.0M | $341.0M | ||
| Q3 24 | $792.0M | $250.0M | ||
| Q2 24 | $391.0M | $268.0M |
自由现金流率CFDGX
| Q1 26 | — | — | ||
| Q4 25 | 16.7% | 10.9% | ||
| Q3 25 | 43.2% | 14.9% | ||
| Q2 25 | 16.8% | 15.8% | ||
| Q1 25 | 27.3% | 7.4% | ||
| Q4 24 | 14.6% | 13.0% | ||
| Q3 24 | 57.8% | 10.0% | ||
| Q2 24 | 24.9% | 11.2% |
资本支出强度CFDGX
| Q1 26 | — | 3.9% | ||
| Q4 25 | 12.1% | 5.6% | ||
| Q3 25 | 20.9% | 5.1% | ||
| Q2 25 | 13.0% | 3.9% | ||
| Q1 25 | 7.9% | 4.4% | ||
| Q4 24 | 12.9% | 4.7% | ||
| Q3 24 | 10.1% | 4.3% | ||
| Q2 24 | 5.3% | 3.8% |
现金转化率CFDGX
| Q1 26 | — | 0.99× | ||
| Q4 25 | 1.09× | 1.90× | ||
| Q3 25 | 2.31× | 2.30× | ||
| Q2 25 | 1.14× | 1.93× | ||
| Q1 25 | 1.67× | 1.43× | ||
| Q4 24 | 1.07× | 2.09× | ||
| Q3 24 | 2.73× | 1.58× | ||
| Q2 24 | 0.94× | 1.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CF
| Ammonia | $591.0M | 32% |
| UAN | $493.0M | 26% |
| Urea | $372.0M | 20% |
| Other | $244.0M | 13% |
| Other Products | $147.0M | 8% |
| Ammonium Nitrate Segment | $25.0M | 1% |
DGX
暂无分部数据
